These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 29346775)

  • 1. BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate Cancer.
    Li X; Baek G; Ramanand SG; Sharp A; Gao Y; Yuan W; Welti J; Rodrigues DN; Dolling D; Figueiredo I; Sumanasuriya S; Crespo M; Aslam A; Li R; Yin Y; Mukherjee B; Kanchwala M; Hughes AM; Halsey WS; Chiang CM; Xing C; Raj GV; Burma S; de Bono J; Mani RS
    Cell Rep; 2018 Jan; 22(3):796-808. PubMed ID: 29346775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TMPRSS2-ERG Gene Fusion Blocks XRCC4-Mediated Nonhomologous End-Joining Repair and Radiosensitizes Prostate Cancer Cells to PARP Inhibition.
    Chatterjee P; Choudhary GS; Alswillah T; Xiong X; Heston WD; Magi-Galluzzi C; Zhang J; Klein EA; Almasan A
    Mol Cancer Ther; 2015 Aug; 14(8):1896-906. PubMed ID: 26026052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BET bromodomain-mediated interaction between ERG and BRD4 promotes prostate cancer cell invasion.
    Blee AM; Liu S; Wang L; Huang H
    Oncotarget; 2016 Jun; 7(25):38319-38332. PubMed ID: 27223260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate Oncogenesis.
    Sandoval GJ; Pulice JL; Pakula H; Schenone M; Takeda DY; Pop M; Boulay G; Williamson KE; McBride MJ; Pan J; St Pierre R; Hartman E; Garraway LA; Carr SA; Rivera MN; Li Z; Ronco L; Hahn WC; Kadoch C
    Mol Cell; 2018 Aug; 71(4):554-566.e7. PubMed ID: 30078722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation-Induced Oxidative Stress Mediates Gene Fusion Formation in Prostate Cancer.
    Mani RS; Amin MA; Li X; Kalyana-Sundaram S; Veeneman BA; Wang L; Ghosh A; Aslam A; Ramanand SG; Rabquer BJ; Kimura W; Tran M; Cao X; Roychowdhury S; Dhanasekaran SM; Palanisamy N; Sadek HA; Kapur P; Koch AE; Chinnaiyan AM
    Cell Rep; 2016 Dec; 17(10):2620-2631. PubMed ID: 27926866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone cross-talk connects protein phosphatase 1α (PP1α) and histone deacetylase (HDAC) pathways to regulate the functional transition of bromodomain-containing 4 (BRD4) for inducible gene expression.
    Hu X; Lu X; Liu R; Ai N; Cao Z; Li Y; Liu J; Yu B; Liu K; Wang H; Zhou C; Wang Y; Han A; Ding F; Chen R
    J Biol Chem; 2014 Aug; 289(33):23154-23167. PubMed ID: 24939842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis.
    Dey A; Chitsaz F; Abbasi A; Misteli T; Ozato K
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8758-63. PubMed ID: 12840145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromatin reader Brd4 functions in Ig class switching as a repair complex adaptor of nonhomologous end-joining.
    Stanlie A; Yousif AS; Akiyama H; Honjo T; Begum NA
    Mol Cell; 2014 Jul; 55(1):97-110. PubMed ID: 24954901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromodomain and extraterminal domain inhibition synergizes with WEE1-inhibitor AZD1775 effect by impairing nonhomologous end joining and enhancing DNA damage in nonsmall cell lung cancer.
    Takashima Y; Kikuchi E; Kikuchi J; Suzuki M; Kikuchi H; Maeda M; Shoji T; Furuta M; Kinoshita I; Dosaka-Akita H; Sakakibara-Konishi J; Konno S
    Int J Cancer; 2020 Feb; 146(4):1114-1124. PubMed ID: 31199520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRD4 inhibition induces synthetic lethality in ARID2-deficient hepatocellular carcinoma by increasing DNA damage.
    He DD; Shang XY; Wang N; Wang GX; He KY; Wang L; Han ZG
    Oncogene; 2022 Mar; 41(10):1397-1409. PubMed ID: 35017665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of BRD4 suppresses tumor growth in prostate cancer via the enhancement of FOXO1 expression.
    Tan Y; Wang L; Du Y; Liu X; Chen Z; Weng X; Guo J; Chen H; Wang M; Wang X
    Int J Oncol; 2018 Dec; 53(6):2503-2517. PubMed ID: 30272279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatially restricted loading of BRD2 at DNA double-strand breaks protects H4 acetylation domains and promotes DNA repair.
    Gursoy-Yuzugullu O; Carman C; Price BD
    Sci Rep; 2017 Oct; 7(1):12921. PubMed ID: 29018219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer.
    Thangapazham R; Saenz F; Katta S; Mohamed AA; Tan SH; Petrovics G; Srivastava S; Dobi A
    BMC Cancer; 2014 Jan; 14():16. PubMed ID: 24418414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNAs interact with BRD4 to promote enhanced chromatin engagement and transcription activation.
    Rahnamoun H; Lee J; Sun Z; Lu H; Ramsey KM; Komives EA; Lauberth SM
    Nat Struct Mol Biol; 2018 Aug; 25(8):687-697. PubMed ID: 30076409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation.
    Wu SY; Chiang CM
    J Biol Chem; 2007 May; 282(18):13141-5. PubMed ID: 17329240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bromodomain protein Brd4 insulates chromatin from DNA damage signalling.
    Floyd SR; Pacold ME; Huang Q; Clarke SM; Lam FC; Cannell IG; Bryson BD; Rameseder J; Lee MJ; Blake EJ; Fydrych A; Ho R; Greenberger BA; Chen GC; Maffa A; Del Rosario AM; Root DE; Carpenter AE; Hahn WC; Sabatini DM; Chen CC; White FM; Bradner JE; Yaffe MB
    Nature; 2013 Jun; 498(7453):246-50. PubMed ID: 23728299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription.
    Dey A; Nishiyama A; Karpova T; McNally J; Ozato K
    Mol Biol Cell; 2009 Dec; 20(23):4899-909. PubMed ID: 19812244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis and binding properties of the second bromodomain of Brd4 with acetylated histone tails.
    Liu Y; Wang X; Zhang J; Huang H; Ding B; Wu J; Shi Y
    Biochemistry; 2008 Jun; 47(24):6403-17. PubMed ID: 18500820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4.
    Dai X; Gan W; Li X; Wang S; Zhang W; Huang L; Liu S; Zhong Q; Guo J; Zhang J; Chen T; Shimizu K; Beca F; Blattner M; Vasudevan D; Buckley DL; Qi J; Buser L; Liu P; Inuzuka H; Beck AH; Wang L; Wild PJ; Garraway LA; Rubin MA; Barbieri CE; Wong KK; Muthuswamy SK; Huang J; Chen Y; Bradner JE; Wei W
    Nat Med; 2017 Sep; 23(9):1063-1071. PubMed ID: 28805820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NKX3.1 Suppresses TMPRSS2-ERG Gene Rearrangement and Mediates Repair of Androgen Receptor-Induced DNA Damage.
    Bowen C; Zheng T; Gelmann EP
    Cancer Res; 2015 Jul; 75(13):2686-98. PubMed ID: 25977336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.